Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 237-272-7 | CAS number: 13718-26-8
Endpoint summary
Administrative data
Description of key information
- Relative density: 2.84
- PSD: D10 = 7.1 μm D50 = 21.8 μm D90 = 56.2 μm
- Dustiness: 71.49 mg/g MMAD1 = 13.56 µm (35.6 %), GSD1 = 2.85; MMAD2 = 38.09 µm (64.4 %), GSD 2 = 1.58
Fractional deposition in human respiratory tract: Head (ET): 43.92 %, Tracheobronchial (TB): 0.38 %, Pulmonary (PU): 0.67 %
- Water solubility: 225.2 ± 5.1 g/L at 20 °C and pH 9.4 -9.6 (exclusion of CO2 and O2, under inert argon gas)
- Transformation / dissolution: 263 ± 12 μg/L at pH 8 and 267 ± 8 μg/L at pH 6
- Oxidizing properties: Not considered relevant for sodium metavanadate based on chemical structure and oxygen content.
Additional information
Data for the physico-chemical properties of sodium metavanadate was provided based on studies for the following endpoints:
(i) density
(ii) granulometry and dustiness testing
(iii) water solubility and transformation/dissolution testing
(iv) oxidising properties
The other endpoints (i.e. appearance, melting point and flammability) are based on handbook data and/or long time experiences in handling.
It is noted here that handbook data for physico-chemical properties are considered to be from a trusted source acc. to "ECHA, Guidance on information requirements and chemical safety assessment – Chapter R.7a: Endpoint specific guidance" and therefore, these data were considered reliable.
The results of the studies are reported in the endpoint summary as well as in the accompanying IUCLID database. Data for several endpoints were waived due to intrinsic properties of sodium metavanadate and/or based on the criteria as laid down in regulation (EC) 1907/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
